Skip to content

Clinical trials

Phase 4 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 4 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20074
20093
20102
20112
20133
20141
20161
20172
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status6
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
PETHEMA Foundation2
Peking Union Medical College Hospital2
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine1
Celgene1
Chinese Society of Hematology1
Cttq1
Eisai Inc.1
H. Lee Moffitt Cancer Center and Research Institute1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes26
Leukemia, Myeloid, Acute6
Iron Overload4
Anemia, Aplastic2
Hematologic Diseases2
Lymphoma2
Neoplasms2
Neoplasms, Plasma Cell2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia1

Trials

Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.